[{"id":"868a48c8-2833-439b-b24b-719061743a69","acronym":"","url":"https://clinicaltrials.gov/study/NCT05113290","created_at":"2021-11-09T12:53:05.983Z","updated_at":"2024-07-02T16:36:17.880Z","phase":"Phase 4","brief_title":"Effect and Safety of Recombinant Human Adenovirus Type 5 in Advanced HCC With Stable Disease After Sorafenib Treatment","source_id_and_acronym":"NCT05113290","lead_sponsor":"First Affiliated Hospital Xi'an Jiaotong University","biomarkers":" AFP","pipe":"","alterations":" ","tags":["AFP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e sorafenib • Oncorine (recombinant human adenovirus type 5)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 66","initiation":"Initiation: 12/28/2021","start_date":" 12/28/2021","primary_txt":" Primary completion: 12/01/2023","primary_completion_date":" 12/01/2023","study_txt":" Completion: 12/01/2023","study_completion_date":" 12/01/2023","last_update_posted":"2022-01-27"},{"id":"6dd650b0-d07e-40b8-81a5-bed6597d302d","acronym":"","url":"https://clinicaltrials.gov/study/NCT02579564","created_at":"2021-01-18T12:30:32.393Z","updated_at":"2024-07-02T16:37:28.336Z","phase":"Phase 3","brief_title":"Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients","source_id_and_acronym":"NCT02579564","lead_sponsor":"Xinqiao Hospital of Chongqing","biomarkers":" EGFR • MUC16","pipe":"","alterations":" ","tags":["EGFR • MUC16"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cisplatin • gemcitabine • paclitaxel • pemetrexed • vinorelbine tartrate • Endostar (recombinant human endostatin) • Oncorine (recombinant human adenovirus type 5)"],"overall_status":"Unknown status","enrollment":" Enrollment 134","initiation":"Initiation: 10/01/2016","start_date":" 10/01/2016","primary_txt":" Primary completion: 06/01/2018","primary_completion_date":" 06/01/2018","study_txt":" Completion: 12/01/2018","study_completion_date":" 12/01/2018","last_update_posted":"2016-10-21"}]